Cleared Traditional

K915494 - NELLCOR STAT-CAP AIRWAY CO2 INDICATOR, MODEL N-60

K915494 is an FDA 510(k) clearance for NELLCOR STAT-CAP AIRWAY CO2 INDICATOR, manufactured by Nellcor, Inc.. The device is a Class 2 Anesthesiology device with product code CCK cleared through the Traditional 510(k) pathway after a 606-day FDA review.

K915494 · Nellcor, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1993
Decision
606d
Days
Class 2
Risk

K915494 is an FDA 510(k) clearance for the NELLCOR STAT-CAP AIRWAY CO2 INDICATOR, MODEL N-60. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Nellcor, Inc. (Hayward, US). The FDA issued a Cleared decision on August 6, 1993 after a review of 606 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

View all Nellcor, Inc. devices

FDA 510(k) Submission Details - K915494

510(k) Number K915494 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 09, 1991
Decision Date August 06, 1993
Days to Decision 606 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
466d slower than avg
Panel avg: 140d · This submission: 606d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCK Device Classification - Class 2, Special Controls

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 192
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K915494.
END TIDAL CO2 OPTION B
K930524 · Medical Data Electronics · Feb 1994
HP M1465A STANDARD AIRWAY ADAPTER
K933980 · Hewlett-Packard Co. · Sep 1993
VITALMAX 800-C
K930559 · Pace Tech, Inc. · Sep 1993
RASCAL II
K930866 · Ohmeda Medical · May 1993
CAPNOMED 100 STAND-ALONE ETCO2 MODULE
K920915 · Mennen Medical, Inc. · Mar 1993
MASS SPECTROMETRY MONITORING LINE CONONECTORS
K925167 · Merit Medical Systems, Inc. · Jan 1993